Navigation Links
Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure
Date:9/17/2009

ee, US adults. Although high blood pressure can be easily diagnosed and often successfully managed, approximately 36% of US adults treated with antihypertensive medication do not have their blood pressure controlled. If left untreated, high blood pressure can lead to stroke, heart attack, heart failure, kidney failure and vision problems.

Valturna, Tekturna and Diovan are not approved to treat or prevent stroke, heart attack, heart failure, kidney failure or eye problems resulting from high blood pressure.

History of Diovan((R)) (valsartan) tablets and Tekturna((R)) (aliskiren) tablets

Diovan, which marked its 10th anniversary in 2007, is the number one selling branded high blood pressure medicine worldwide. Diovan's extensive clinical trials program demonstrates the longstanding commitment of Novartis to research.

Tekturna is a direct renin inhibitor in the first new approved class of high blood pressure medicine in more than a decade. Tekturna was approved by the FDA in March 2007 for the treatment of high blood pressure as monotherapy or in combination with other high blood pressure medications. The use of Tekturna in combination with maximal doses of angiotensin-converting enzyme (ACE) inhibitors has not been adequately studied.

The long-term potential of the direct renin inhibitor Tekturna is being evaluated in an extensive clinical program known as ASPIRE HIGHER.

Novartis and Hypertension Management

For decades Novartis has been a leader and innovator in hypertension management, offering a range of innovative therapies designed to help patients with different needs achieve their blood pressure goals. Novartis is dedicated to helping physicians and patients improve cardiovascular and metabolic health through effective medicines, programs and an ongoing commitment to research.

Valturna is avai
'/>"/>

SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
2. Lifeclinic Supports the Novartis and International Association of Fire Fighters Campaign Against Hypertension
3. Video: Novartis Receives Approval From FDA to Market Prevacid(R) 24HR as First and Only OTC Proton Pump Inhibitor in Original Prescription Formulation
4. J&J, Schering-Plough, Novartis, Bayer vie for Top Honors at the Premier OTC / Healthcare Ad Awards
5. Novartis Oncology Launches GIST Alliance™ for Patients and Caregivers
6. Novartis Oncology Launches GIST Alliance™ for Healthcare Professionals Treating Gastrointestinal Stromal Tumors
7. Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration
8. Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity
9. Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients
10. Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
11. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... ... 2015 , ... Brands like Toppik , Eau Thermale Avene and Bliss ... a threshold of $49.00 was required to qualify for free standard shipping,” said Jennifer ... shipping for customers regardless of the item’s selling price.” , With competitive pricing in ...
(Date:8/29/2015)... ... August 29, 2015 , ... The popular television program VOICES ... recently announced that it will be devoting an entire short segment to the subject ... people around the globe on a daily basis, but recent advancements in medical science ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Day at the Zoo to celebrate children helping children, a thank you to ... throughout West Ohio have contributed to the United Methodist initiative to end malaria ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Understanding the FDA’s Position and Best Practices for Compliance, **Presented by FDAnews ... This workshop, chaired by internationally renowned expert Fubin Wu, has been specifically ...
(Date:8/28/2015)... ... August 28, 2015 , ... Saint Petersburg, FL —Pocket Protein™, ... fat, carbs, sugar, gluten, lactose or caffeine in a convenient 2 oz. pouch ... CPG Editor’s Choice Awards. , Five consumer packaged goods (CPG) products were selected ...
Breaking Medicine News(10 mins):Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3
... those who have been hospitalized, risk may double over 7 ... Certain depressed patients who suffer from heart disease have nearly ... with other depressed patients, researchers say. , The patients ... severe depression within a few weeks of being hospitalized for ...
... of Tropical Medicine (LSTM) and Liverpool Associates in Tropical ... UK,s Department for International Development (DFID) to set up ... The IHLC will act as a ,one-stop-shop, source ... developers of links and those wishing to strengthen existing ...
... complications seen with ,after-hours, procedures, study finds , MONDAY, ... slot to undergo an orthopedic procedure may lower your ... new study has found. , The study, published ... Bone and Joint Surgery , found little difference otherwise ...
... Regurin(R) XL (trospium chloride), a,once-daily, prolonged-release capsule to ... the UK. Regurin(R) XL provides rapid,significant and consistent improvements ... for central nervous system (CNS) side effects(2-7). , ... is a condition that results from,sudden, involuntary contraction of ...
... ... supplier of medical devices, today announced FDA clearance of new RT50 wireless stimulator modules ... stimulation (FES) motorized ergometer system. , ... Baltimore, MD(PRWEB) September 5, 2009 -- Restorative Therapies, Inc., a designer ...
... , , ... Cell Technologies, Inc., ("Stemedica"), a world leader in stem cell research ... breakthrough stem cell and related technology. The Jordanian Stem Cell ... the technology from Stemedica,s wholly-owned subsidiary, Stemedica International, S.A. The ...
Cached Medicine News:Health News:Severe, Lasting Depression Tied to Heart Patient Deaths 2Health News:Creation of international health links center 2Health News:Let Orthopedic Surgery Wait Until Morning When Possible 2Health News:REGURIN(R) XL (trospium chloride) Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 2Health News:REGURIN(R) XL (trospium chloride) Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 3Health News:REGURIN(R) XL (trospium chloride) Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 4Health News:REGURIN(R) XL (trospium chloride) Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 5Health News:Restorative Therapies, Inc., Receives FDA Clearance for RT300 Enhancements 2Health News:Restorative Therapies, Inc., Receives FDA Clearance for RT300 Enhancements 3Health News:The Jordanian Stem Cell Company Acquires Stem Cell Technology From Stemedica International S.A. 2Health News:The Jordanian Stem Cell Company Acquires Stem Cell Technology From Stemedica International S.A. 3
(Date:8/27/2015)... 2015 Biosimilars are not generics and ... Food and Drug Administration (FDA) for recognizing that ... draft guidance issued today. The FDA,s draft guidance ... names, calling for biological products to bear a ... proposal reflects the agency,s thinking that "there is ...
(Date:8/27/2015)... India , August 27, 2015 According ... Product (Transfer, Hammock, Toilet, Seating, Universal, Standing, Bariatric ), Material (Nylon, ... - Forecast to 2020", published by MarketsandMarkets, the Medical Lifting Sling ... USD 411.5 Million in 2015, at a CAGR of 11.4 % ... 136 ma rket data T ables and ...
(Date:8/27/2015)... , Aug. 27, 2015  Now that Intuitive Surgical, ... Vinci S™ surgical robot, hospitals with robotic surgery programs ... also need to see where they stand with robotic ... right patients? Have they adopted best practices for safety? ... in the future? ECRI Institute, which has ...
Breaking Medicine Technology:Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 3
... Cannabis Science, Inc. (OTCBB: CBIS.OB), a pioneering US ... report an additional, apparently successful, self-medicated cannabis treatment for ... nature. One of the patient,s physicians said it was ... had ever seen, while another refused to continue tending ...
... 2012 Fleming Pharmaceuticals announced today that, effective December ... branded Ocean®, Nephrocaps®, Magonate® and ProBarimin QT® products to ... affiliate, Valeant Pharmaceuticals North America LLC, to act as ... Fleming also manufactures contract products for a broad ...
Cached Medicine Technology:Cannabis Science Reports Apparent Success for 3rd Self-Medicated Cancer Patient 2Cannabis Science Reports Apparent Success for 3rd Self-Medicated Cancer Patient 3
Colloidal Gold Conjugated, Rabbit anti-goat IgG (H&L) - 12 OD...
Colloidal Gold Conjugated, Protein A - 50 OD...
Colloidal Gold Conjugated, Protein G - 50 OD...
Polyester ribbon impregnated with conjugated Protein G - .25 OD per sq. cm....
Medicine Products: